Showing results (2431-2440 of 2,889) with videos related to

Sort By:
Pageof 289
Oncogene|April 4, 2017
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cellsH S Madapura, N Nagy, D Ujvari, et al.
Clinical Genitourinary Cancer|June 21, 2023
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy StudyFady Ghali, Funda Vakar-Lopez, Martine P Roudier, et al.
The Oncologist|May 11, 2026
A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-Resistant Prostate CancerJulie N Graff, Claire E P Smith, Alexandra O Sokolova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2003
Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segmentsMichael Emerson, Louise Renwick, Stephen Tate, et al.
Plos One|July 9, 2011
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseKaren M Ashe, Dinesh Bangari, Lingyun Li, et al.
Echocardiography (Mount Kisco, N.Y.)|February 23, 2007
Live/real time three-dimensional transthoracic echocardiographic assessment of left ventricular volumes, ejection fraction, and mass compared with magnetic resonance imagingXin Qi, Bryan Cogar, Ming Chon Hsiung, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 5, 2023
Occupancy of orbitals and the quadrupole collectivity inA Rohilla, J G Wang, G S Li, et al.
Annals of Neurology|April 8, 2011
Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processingValerie Cullen, S Pablo Sardi, Juliana Ng, et al.
British Journal of Haematology|November 18, 2003
Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non-functional variant transcriptMargaret H L Ng, K M Lau, W S Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2013
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitmentVernon T Phan, Xiumin Wu, Jason H Cheng, et al.
Pageof 289